|
Publication List - Rohmad.Yudi Utomo (10 entries)
Journal Paper
-
R. Y. Utomo,
S. Okada,
A. Sumiyoshi,
I. Aoki,
H. Nakamura.
Development of an MRI contrast agent for both detection and inhibition of the amyloid-β fibrillation process,
RSC Adv.,
Feb. 2022.
-
R. Y. Utomo,
A. Sugie,
S. Okada,
K. Miura,
H. Nakamura.
Detoxification of amyloid β fibrils by curcumin derivatives and their verification in a Drosophila Alzheimer's model,
Chem. Commun.,
58,
2576-2579,
Jan. 2022.
-
R. Yudi Utomo,
Y. Asawa,
S. Okada,
A. Yoshimori,
J. Bajorath,
H. Nakamura.
Development of curcumin-based amyloid β aggregation inhibitors for Alzheimer's disease using the SAR matrix-approach,
The International Center for Chemical and Biological Sciences (ICCBS-2021),
Bioorg. Med. Chem.,
46,,
116357,
Feb. 2021.
Domestic Conference (Not reviewed / Unknown)
-
Hiroyuki Nakamura,
Rohmad.Yudi Utomo,
Satoshi Okada,
住吉晃,
Ichio Aoki.
アミロイドβ繊維化を検出・阻害するMRIプローブの開発,
日本化学会第102春季年会,
Mar. 2022.
-
Rohmad.Yudi Utomo,
Atsushi Sugie,
Satoshi Okada,
Kazuki Miura,
Hiroyuki Nakamura.
Curcumin誘導体のアミロイドβ繊維の解離を介した解毒作用とショウジョウバエのアルツハイマー病モデルにおける検証,
日本薬学会142春季年会,
Mar. 2022.
-
Rohmad Yudi Utomo,
Yasunobu Asawa,
Atsushi Yoshimori,
Hiroyuki Nakamura.
Novel Curcumin Derivatives Generated from SAR Matrix Possess as Amyloid β Inhibitors for Alzheimer?s Disease,
第64回日本薬学会関東支部大会(オンライン),
Sept. 2020.
-
Rohmad Yudi Utomo,
Yasunobu Asawa,
Shinichi Sato,
Atsushi Yoshimori,
Hiroyuki Nakamura.
Novel Curcumin Derivatives Generated from SAR Matrix Possess as Amyloid β Inhibitors,
日本薬学会第140年会,
Mar. 2020.
Degree
-
SAR Matrix-Assisted Design of Curcumin Derivatives as Amyloid β Inhibitors and Their Application to MRI Contrast Agents for Alzheimer’s Disease,
Exam Summary,
Doctor (Science),
Tokyo Institute of Technology,
2022/03/26,
-
SAR Matrix-Assisted Design of Curcumin Derivatives as Amyloid β Inhibitors and Their Application to MRI Contrast Agents for Alzheimer’s Disease,
Thesis,
Doctor (Science),
Tokyo Institute of Technology,
2022/03/26,
-
SAR Matrix-Assisted Design of Curcumin Derivatives as Amyloid β Inhibitors and Their Application to MRI Contrast Agents for Alzheimer’s Disease,
Summary,
Doctor (Science),
Tokyo Institute of Technology,
2022/03/26,
[ Save as BibTeX ]
[ Paper, Presentations, Books, Others, Degrees: Save as CSV
]
[ Patents: Save as CSV
]
|